Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant Data
Stroke2024Vol. 55(12), pp. 2825–2834
Citations Over TimeTop 10% of 2024 papers
John McCabe, Cathal Walsh, Sarah Gorey, Markus Arnold, Gian Marco De Marchis, Katie Harris, Pablo Hervella, Ramón Iglesias‐Rey, Christina Jern, Mira Katan, Linxin Li, Nobukazu Miyamoto, Joan Montaner, Francisco Purroy, Peter M. Rothwell, Tara M. Stanne, Cathie Sudlow, Yuji Ueno, Mikel Vicente‐Pascual, William Whiteley, Mark Woodward, Peter J. Kelly
Abstract
Timing of sample measurement after stroke modifies the association with recurrent major adverse cardiovascular events for IL-6 but not hsCRP. These data inform future randomized controlled trial designs incorporating biomarker-based selection of patients for anti-inflammatory therapies.
Related Papers
- → Efficacy and safety of lung recruitment in pediatric patients with acute lung injury(2010)56 cited
- → Hemoglobin Levels Across the Pediatric Critical Care Spectrum: A Point Prevalence Study*(2018)8 cited
- → Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease.(2013)9 cited
- → Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia(2022)3 cited
- 效果热门在有干燥眼睛疾病的病人的角膜的内皮细胞层上的 0.05% cyclosporine A(2013)